Opening of the Procedure for Compulsory Licensing of Dolutegravir in Colombia
Opening of the Procedure for Compulsory Licensing of Dolutegravir in Colombia On June 2, 2023, the Ministry of Health and Social Protection of Colombia initiated ex officio the administrative procedure to subject the patents of the drug Dolutegravir to compulsory licensing on grounds of public interest. In Resolution 0881, the Ministry states that the primary…
